No Data
No Data
Stifel Maintains ALX Oncology(ALXO.US) With Hold Rating, Cuts Target Price to $1.5
ALX Oncology Is Maintained at Hold by Stifel
ALX Oncology Holdings Shares Are Trading Lower. The Company Reported Q4 Financial Results.
A Quick Look at Today's Ratings for ALX Oncology(ALXO.US), With a Forecast Between $1.5 to $9
Analysts Offer Insights on Healthcare Companies: Mind Medicine (MNMD), IGM Biosciences (IGMS) and ALX Oncology Holdings (ALXO)
Express News | ALX Oncology Holdings Inc : Stifel Cuts Target Price to $1.5 From $3
Unlock the Full List
72506401 : Thanks to you, I made a bit of $ myself on this
Triple Nickle 1 : careful
Trytosaveabit OP 72506401 : Thats awesome! Im happy but you gotta give yourself credit as well! You decided to trade it! I dont give buy/sell advice! And im very careful with my wording with things like this! And its not that i dont want to. Its because i have NO WAY to know others risk tolerance. Or how they will trade it. And there is also me being wrong! Because, believe me im definitely fallible. Hehehe. Being honest, if i know 100% that a ticker would go up. And knew exactly how much. I would give that to all my followers. Anyways sorry so long a answer to just say CONGRATS on a great trade! Hehehe WTG

Trytosaveabit OP Triple Nickle 1 : K thanks. you to.
Triple Nickle 1 : spoke to friends 1.50
View more comments...